MODIFYING METABOLISM FOR THE TREATMENT OF CHRONIC METABOLIC DISEASES

Cirius Therapeutics is a clinical-stage pharmaceutical company developing innovative therapies for diseases caused by insulin resistance including Type 2 Diabetes, the metabolic consequences of Obesity, and MASLD/MASH